Metraipolis › archive › dc_4ea4549a80d7

Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415 — Europe PMC PMID:33852571

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/33852571
DOI
10.1371/journal.pone.0249123
License (as archived)
CC0-1.0
Archived
2026-11-05T00:46:38.994Z
SHA-256 of the archived text
460eb05cadb857aad18cc675842c3077930fa675b373b0c9e915c4d57be75291
Stable URL of this page
https://metraipolis.com/documento/dc_4ea4549a80d7

How to cite

Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415 — Europe PMC PMID:33852571 — Europe PMC (en), https://europepmc.org/article/MED/33852571 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_4ea4549a80d7 (Metraipolis archive dc_4ea4549a80d7, sha256 460eb05cadb857aad18cc675842c3077930fa675b373b0c9e915c4d57be75291)
BibTeX
@misc{dc4ea4549a80d7,
  title = {Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415 — Europe PMC PMID:33852571},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/33852571},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_4ea4549a80d7; sha256 460eb05cadb857aad18cc675842c3077930fa675b373b0c9e915c4d57be75291},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/33852571. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Purpose: The Expanded Prostate Cancer Index Composite (EPIC) is the most commonly used patient reported outcome (PRO) tool in prostate cancer (PC) clinical trials, but health utilities associated with the different health states assessed with this tool are unknown, limiting our ability to perform cost-utility analyses. This study aimed to map EPIC tool to EuroQoL-5D-3L (EQ5D) to generate EQ5D health utilities. Methods and materials: This is a secondary analysis of a prospective, randomized non-inferiority clinical trial, conducted between 04/2006 and 12/2009 at cancer centers across the United States, Canada, and Switzerland. Eligible patients included men >18 years with a known diagnosis of low-risk PC. Patient HRQoL data were collected using EPIC and health utilities were obtained using EQ5D. Data were divided into an estimation sample (n = 765, 70%) and a validation sample (n = 327, 30%). The mapping algorithms that capture the relationship between the instruments were estimated using ordinary least squares (OLS), Tobit, and two-part models. Five-fold cross-validation (in-sample) was used to compare the predictive performance of the estimated models. Final models were selected based on root mean square error (RMSE). Results: A total of 565 patients in the estimation sample had complete information on both EPIC and EQ5D questionnaires at baseline. Mean observed EQ5D utility was 0.90±0.13 (range: 0.28-1) with 55% of patients in full health. OLS models outperformed their counterpart Tobit and two-part models for all pre-determined model specifications. The best model fit was: "EQ5D utility = 0.248541 + 0.000748*(Urinary Function) + 0.001134*(Urinary Bother) + 0.000968*(Hormonal Function) + 0.004404*(Hormonal Bother)- 0.376487*(Zubrod) + 0.003562*(Urinary Function*Zubrod)"; RMSE was 0.10462. Conclusions: This is the first study to identify a comprehensive set of mapping algorithms to generate EQ5D utilities from EPIC domain/ sub-domain scores. The study results will help estimate quality-adjusted life-years in PC economic evaluations.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2021 (prima pubblicazione 2021-04-14).
Identificativi: PMID 33852571 · PMCID PMC8046237 · DOI 10.1371/journal.pone.0249123.
Descrittori MeSH principali: Quality-Adjusted Life Years; Cost of Illness.
Pagina: https://europepmc.org/article/MED/33852571 — https://doi.org/10.1371/journal.pone.0249123. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-05T00:43:19.534Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.